ERBB2 and endometrial cancer: Activation of GPCR, HER-2 and integrin receptors, leading to PI3K and PKA activation, leading to oxidative phosphorylation and CA2+ signaling, leading to EMT and senescence, are implicated in endometrial cancer metastasis, along with ER-mediated transcription and loss of PTEN activation.